Publication | Closed Access
Long-term suppression maintained after cessation of AB-729 treatment and comparable on-treatment response observed in HBeAg+ subjects
10
Citations
0
References
2022
Year
ThrombosisHematologyHemostasisHbeag+ SubjectsPharmacotherapyCoagulopathyAb-729 TreatmentMedicineAnticoagulantAnesthesiologyLong-term Suppression
No additional data available for this publication yet. Check back later!